showed a trendp = 0.07
Treatment with HSP60 peptide 180-188 alone showed a trend towards reduction of arthritis, without achievement of statistically significant differences (Day 23 p = 0.07, AUC p = 0.26 vs. no treatment).
Treatment with HSP60 peptide 180-188 alone showed a trend towards reduction of arthritis, without achievement of statistically significant differences (Day 23 p = 0.07, AUC p = 0.26 vs. no treatment).
ILN were able to induce a good level of clinical amelioration ( Figure 5-B ), however differences with no treatment control group did not reach statistical significance ( Figure 5-A ).